HONG KONG – A new study has demonstrated for the first time that nanomolar concentrations of a candidate cancer compound may also have therapeutic value in the field of stem cell therapy and tissue regeneration, Chinese researchers reported in the May 9, 2016, early online edition of Proceedings of the National Academy of Sciences.